Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-α-acetyltransferase complex

被引:87
作者
Arnesen, T.
Gromyko, D.
Pendino, F.
Ryningen, A.
Varhaug, J. E.
Lillehaug, J. R.
机构
[1] Univ Bergen, Dept Mol Biol, Bergen High Technol Ctr, N-5020 Bergen, Norway
[2] Univ Bergen, Dept Surg Sci, N-5020 Bergen, Norway
[3] Haukeland Univ Hosp, Dept Med, N-5021 Bergen, Norway
关键词
apoptosis; NATH; hARD1; protein N-acetylation; siRNA; daunorubicin;
D O I
10.1038/sj.onc.1209469
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein N-epsilon-acetylation is recognized as an important modi. cation influencing many biological processes, and protein deacetylase inhibitors leading to N-epsilon-hyperacetylation of histones are being clinically tested for their potential as anticancer drugs. In contrast to N-epsilon-acetyltransferases, the N-alpha-acetyltransferases transferring acetyl groups to the alpha-amino groups of protein N-termini have only been briefly described in mammalians. Human arrest defective 1(hARD1), the only described human enzyme in this class, complexes with N-acetyltransferase human (NATH) and cotranslationally transfers acetyl groups to the N-termini of nascent polypeptides. Here, we demonstrate that knockdown of NATH and/or hARD1 triggers apoptosis in human cell lines. Knockdown of hARD1 also sensitized cells to daunorubicin-induced apoptosis, potentially pointing at the NATH-hARD1 acetyltransferase complex as a novel target for chemotherapy. Our results argue for an essential role of the NATH-hARD1 complex in cell survival and underscore the importance of protein N-alpha-acetylation in mammalian cells.
引用
收藏
页码:4350 / 4360
页数:11
相关论文
共 27 条
  • [1] Interaction between HIF-1α (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1α
    Arnesen, T
    Kong, X
    Evjenth, R
    Gromyko, D
    Varhaug, JE
    Lin, Z
    Sang, NL
    Caro, J
    Lillehaug, JR
    [J]. FEBS LETTERS, 2005, 579 (28): : 6428 - 6432
  • [2] Expression of N-acetyl transferase human and human arrest defective 1 proteins in thyroid neoplasms
    Arnesen, T
    Gromyko, D
    Horvli, O
    Fluge, O
    Lillehaug, J
    Varhaug, JE
    [J]. THYROID, 2005, 15 (10) : 1131 - 1136
  • [3] Identification and characterization of the human ARD1-NATH protein acetyltransferase complex
    Arnesen, T
    Anderson, D
    Baldersheim, C
    Lanotte, M
    Varhaug, JE
    Lillehaug, JR
    [J]. BIOCHEMICAL JOURNAL, 2005, 386 : 433 - 443
  • [4] RAR-independent RXR signaling induces t(15;17) leukemia cell maturation
    Benoit, G
    Altucci, L
    Flexor, M
    Ruchaud, S
    Lillehaug, J
    Raffelsberger, W
    Gronemeyer, H
    Lanotte, M
    [J]. EMBO JOURNAL, 1999, 18 (24) : 7011 - 7018
  • [5] Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1α and is not induced by hypoxia or HIF
    Bilton, R
    Mazure, N
    Trottier, E
    Hattab, M
    Déry, MA
    Richard, DE
    Pouysségur, J
    Brahimi-Horn, MC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (35) : 31132 - 31140
  • [6] Acetylation of proteins as novel target for antitumor therapy: Review article
    Di Gennaro, E
    Bruzzese, F
    Caraglia, M
    Abruzzese, A
    Budillon, A
    [J]. AMINO ACIDS, 2004, 26 (04) : 435 - 441
  • [7] THE MECHANISM OF N-TERMINAL ACETYLATION OF PROTEINS
    DRIESSEN, HPC
    DEJONG, WW
    TESSER, GI
    BLOEMENDAL, H
    [J]. CRC CRITICAL REVIEWS IN BIOCHEMISTRY, 1985, 18 (04): : 281 - 325
  • [8] Many cuts to ruin:: a comprehensive update of caspase substrates
    Fischer, U
    Jänicke, RU
    Schulze-Osthoff, K
    [J]. CELL DEATH AND DIFFERENTIATION, 2003, 10 (01) : 76 - 100
  • [9] Analysis of ARD1 function in hypoxia response using retroviral RNA interference
    Fisher, TS
    Des Etages, S
    Hayes, L
    Crimin, K
    Li, BY
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (18) : 17749 - 17757
  • [10] NATH, a novel gene overexpressed in papillary thyroid carcinomas
    Fluge, O
    Bruland, O
    Akslen, LA
    Varhaug, JE
    Lillehaug, JR
    [J]. ONCOGENE, 2002, 21 (33) : 5056 - 5068